HUP0400589A2 - Kolosztrumalapú készítmény - Google Patents

Kolosztrumalapú készítmény

Info

Publication number
HUP0400589A2
HUP0400589A2 HU0400589A HUP0400589A HUP0400589A2 HU P0400589 A2 HUP0400589 A2 HU P0400589A2 HU 0400589 A HU0400589 A HU 0400589A HU P0400589 A HUP0400589 A HU P0400589A HU P0400589 A2 HUP0400589 A2 HU P0400589A2
Authority
HU
Hungary
Prior art keywords
colostrum
derived
infection
prevention
hyperimmune milk
Prior art date
Application number
HU0400589A
Other languages
English (en)
Inventor
Peter Graeme Hobman
Charles Edward Williams
Simon Stephen Yarrow
Original Assignee
Fonterra Co-Operative Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fonterra Co-Operative Group Limited filed Critical Fonterra Co-Operative Group Limited
Publication of HUP0400589A2 publication Critical patent/HUP0400589A2/hu
Publication of HUP0400589A3 publication Critical patent/HUP0400589A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgyát képezik a következők: - Készítmény, amelykolosztrumot vagy kolosztrumeredetű teméket és hiperimmun tejet (HIM)vagy hiperimmun tejből származó terméket tartalmaz olyanmenynyiségekben, amely elegendő a patogén szervezetek széles spektrumaelleni patogénkötő-aktivitás kombinált spektruma biztosításához. - Afenti készítmények fertőzéssel összefüggő betegség kezelésére vagymegelőzésére, - Kolosztrumot vagy kolosztrumeredetű terméket éshiperimmun tejet (HIM) vagy hiperimmun tejből származó termékettartalmazó készítmény alkalmazása fertőzéssel összefüggő ésgyulladásos betegség kezelésére vagy megelőzésére szolgáló készítményelőállításában. A találmány tárgyát képező készítmények és eljárásokalkalmazhatóak a klinikai gyakorlatban fertőzéssel összefüggő ésgyulladásos betegség kezelésére vagy megelőzésére. Ó
HU0400589A 2000-11-15 2001-11-15 Colostrum-based composition HUP0400589A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ50823400 2000-11-15
PCT/NZ2001/000256 WO2002040051A1 (en) 2000-11-15 2001-11-15 Colostrum-based composition

Publications (2)

Publication Number Publication Date
HUP0400589A2 true HUP0400589A2 (hu) 2004-06-28
HUP0400589A3 HUP0400589A3 (en) 2005-06-28

Family

ID=19928242

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400589A HUP0400589A3 (en) 2000-11-15 2001-11-15 Colostrum-based composition

Country Status (8)

Country Link
US (2) US20040047856A1 (hu)
EP (1) EP1341554A4 (hu)
JP (1) JP2004517067A (hu)
KR (1) KR20030051822A (hu)
CN (1) CN1299771C (hu)
AU (1) AU2002224240A1 (hu)
HU (1) HUP0400589A3 (hu)
WO (1) WO2002040051A1 (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
WO2003080082A1 (en) * 2002-03-21 2003-10-02 Anadis Ltd Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
SE0203265D0 (sv) * 2002-11-06 2002-11-06 Coloplus Ab A feed or food product composition
US20040137072A1 (en) * 2003-01-13 2004-07-15 Richard Cockrum Method for increasing calcium absorption and bone mineral density through the supplementation of bovine colostrum
US6998392B2 (en) * 2003-04-02 2006-02-14 Mti Meta Tech Inc. Formulation to treat or prevent parasitic infection
US7851451B2 (en) * 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
US8536140B2 (en) * 2004-03-12 2013-09-17 Mti Meta Tech Inc. Methods for treating inflammatory bowel disease
JP4965063B2 (ja) 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
US20060013890A1 (en) * 2004-06-24 2006-01-19 Green Shawn J Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
US20070025980A1 (en) * 2005-07-27 2007-02-01 Krogsgaard David L Composition permitting muscle growth while protecting joint health
EP1926834A4 (en) 2005-09-20 2009-04-22 Prolacta Bioscience Inc METHOD FOR ANALYZING MILK
JP5035865B2 (ja) * 2005-09-26 2012-09-26 国立大学法人高知大学 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ菌株の増殖・運動抑制方法
US20070087002A1 (en) * 2005-10-14 2007-04-19 Green Shawn J Anticholesterol immunoglobulin to treat lipid raft diseases
US8071101B2 (en) * 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
DK2392343T3 (en) * 2006-07-03 2019-01-28 Perraudin Jean Paul Antimicrobial compositions comprising hypohalite and / or hypothiocyanite and applications thereof
CA2706722C (en) * 2006-11-29 2016-01-12 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
WO2009020748A2 (en) * 2007-07-16 2009-02-12 Avaxia Biologics, Inc. Antibody therapy for modulating function of intestinal receptors
WO2009046168A1 (en) 2007-10-02 2009-04-09 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
CA2745099C (en) * 2008-12-02 2017-11-07 Prolacta Bioscience, Inc. Human milk permeate compositions and methods of making and using same
US20110020461A1 (en) * 2009-07-27 2011-01-27 Harry Leneau Hyaluronate and colostrum compositions and methods of using the same
US20110086017A1 (en) * 2009-10-08 2011-04-14 Svetlana Kravets Medical Food composition and methods for management of inflammatory processes in mammals
NL2004099C2 (en) * 2010-01-15 2011-07-18 Friesland Brands Bv Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof.
WO2013020081A2 (en) 2011-08-03 2013-02-07 Prolacta Bioscience, Inc. Microfiltration of human milk to reduce bacterial contamination
CN104955344A (zh) * 2012-12-18 2015-09-30 雅培制药有限公司 包含神经保护膳食寡糖的营养组合物
AU2014241754B2 (en) 2013-03-13 2017-11-30 Prolacta Bioscience, Inc. High fat human milk products
WO2017117409A1 (en) 2015-12-30 2017-07-06 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
CN107684078A (zh) * 2017-10-19 2018-02-13 深圳市德荟堂生物科技有限公司 一种乳钙制品及其生产工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
JPH0768135B2 (ja) * 1985-03-29 1995-07-26 株式会社ヤクルト本社 ボツリヌス毒素の中和剤
US5198213A (en) * 1985-04-15 1993-03-30 Protein Technology, Inc. Method of disease treatment utilizing an immunologically whey fraction
US4699789A (en) * 1985-09-27 1987-10-13 Eastern Artificial Insemination Cooperative, Inc. Viral free semen and methods of producing the same
US6015882A (en) * 1992-05-29 2000-01-18 The Regents Of The University Of California Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment of Cryptosporidium parvum infections
CA2089630A1 (en) * 1992-11-05 1994-05-06 Cesar M. Libenson Process for obtaining antibodies against human and animal immunoglobulins from the colostrum and milk for mammals immunized with the respective immunoglobulins
US5591434A (en) * 1993-05-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture DNA sequence encoding surface protein of cryptosporidium parvum
EP0961547A4 (en) * 1996-08-23 2002-08-14 Univ North Carolina State NEUTRALIZATION SENSITIVE EPITROPE OF CRYPTOSPORIDIUM PARVUM
NZ530805A (en) * 1999-12-21 2005-12-23 Merial Sas Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen

Also Published As

Publication number Publication date
CN1299771C (zh) 2007-02-14
JP2004517067A (ja) 2004-06-10
US20040047856A1 (en) 2004-03-11
US20050220894A1 (en) 2005-10-06
EP1341554A4 (en) 2005-06-15
CN1486194A (zh) 2004-03-31
KR20030051822A (ko) 2003-06-25
EP1341554A1 (en) 2003-09-10
WO2002040051A1 (en) 2002-05-23
HUP0400589A3 (en) 2005-06-28
AU2002224240A1 (en) 2002-05-27

Similar Documents

Publication Publication Date Title
HUP0400589A2 (hu) Kolosztrumalapú készítmény
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
HUP0303728A2 (hu) Tápanyagkészítmény
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004024068A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
ATE425248T1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0301819A2 (hu) Illóolajok alkalmazása Helicobacter-szerű organizmusok által előidézett gyomor- és bélrendszeri fertőzések leküzdésére
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
TR200100637T2 (tr) Yeni doğal ürün türevleri
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease
ATE204759T1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
DE60311351D1 (de) Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases